SLC2A1 and pulmonary fibrosis: Phloretin can activate AMP-activated protein kinase via inhibiting GLUT1-dependent glycolysis, modulate key metabolic pathways of fibroblast activation, and significantly inhibit bleomycin-induced pulmonary fibrosis in mice (Cho et al., 2017).